Increase of matrix metalloproteinase-2 in dialysate of rat sclerosing encapsulating peritonitis model

被引:13
作者
Hirahara, I
Umeyama, K
Shofuda, K
Kusano, E
Masunaga, Y
Honma, S
Asano, Y
机构
[1] Terumo Co Ltd, Ctr Res & Dev, Nakai, Kanagawa 2590151, Japan
[2] Jichi Med Sch, Dept Nephrol, Minami Kawachi, Tochigi 32904, Japan
关键词
continuous ambulatory peritoneal dialysis; matrix metalloproteinase-2; sclerosing encapsulating peritonitis;
D O I
10.1046/j.1440-1797.2002.00100.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Sclerosing peritonitis (SP) and sclerosing encapsulating peritonitis (SEP) are serious complications of continuous ambulatory peritoneal dialysis (CAPD). The mortality rate of SP/SEP is extremely high. It is important to clarify the mechanism of progression of SP/SEP, and to prevent this complication. We prepared an animal model of SEP by intraperitoneal administration of chlorhexidine gluconate (CHX) using male Sprague-Dawley rats. Dialysate drained from these animals was analysed by gelatin zymography. In this animal model of SEP, fibrous peritoneal thickening accompanied by cellular infiltration and peritoneal adhesion, were observed. Four of six rats presented with a so-called abdominal cocoon. An increase of peritoneal absorption of glucose was also confirmed. Zymographic analysis revealed that the matrix metalloproteinase-2 (MMP-2) level was high in the dialysate from the animal model, although MMP-9 was hardly detected. From these results, the MMP-2 level in drained dialysate was considered to increase in SP/SEP. Matrix metalloproteinase-2 might be associated with the progression of SP/SEP.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 32 条
[1]  
COLLIER IE, 1988, J BIOL CHEM, V263, P6579
[2]   Abdominal cocoon in a man - Preoperative diagnosis and literature review [J].
Deeb, LS ;
Mourad, FH ;
El-Zein, YR ;
Uthman, SM .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 26 (02) :148-150
[3]  
DOBBIE JW, 1992, PERITON DIALYSIS INT, V12, P14
[4]  
Fujii T, 1999, ANAT RECORD, V254, P465
[5]  
Fukuda Y, 1998, LAB INVEST, V78, P687
[6]   Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients [J].
Fukudome, K ;
Fujimoto, S ;
Sato, Y ;
Hisanaga, S ;
Eto, T .
NEPHRON, 2001, 87 (01) :35-41
[7]   SCLEROTIC THICKENING OF THE PERITONEAL MEMBRANE IN MAINTENANCE PERITONEAL-DIALYSIS PATIENTS [J].
GANDHI, VC ;
HUMAYUN, HM ;
ING, TS ;
DAUGIRDAS, JT ;
JABLOKOW, VR ;
IWATSUKI, S ;
GEIS, WP ;
HANO, JE .
ARCHIVES OF INTERNAL MEDICINE, 1980, 140 (09) :1201-1203
[8]   ULTRASOUND CHANGES IN SCLEROSING PERITONITIS FOLLOWING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].
HOLLMAN, AS ;
MCMILLAN, MA ;
BRIGGS, JD ;
JUNOR, BJR ;
MORLEY, P .
CLINICAL RADIOLOGY, 1991, 43 (03) :176-179
[9]   Matrix degradation in renal disease [J].
Jones, CL .
NEPHROLOGY, 1996, 2 (01) :13-23
[10]  
JUNOR BJR, 1985, PERITON DIALYSIS B, V5, P101